参附脱毒胶囊Ⅱ期临床110例双盲评估研究 |
| |
引用本文: | 张锐敏,李吉祥,孙新会,郑玲,杨丽萍,张杰,李建华,马克坚,袁小波,万文鹏.参附脱毒胶囊Ⅱ期临床110例双盲评估研究[J].中国药物依赖性杂志,2002,11(3):197-201,232. |
| |
作者姓名: | 张锐敏 李吉祥 孙新会 郑玲 杨丽萍 张杰 李建华 马克坚 袁小波 万文鹏 |
| |
作者单位: | 云南省药物依赖防治研究所,昆明,650228 |
| |
摘 要: | 目的··:评价参附脱毒胶囊用于阿片类依赖者脱毒治疗的疗效及不良反应。方法··:110例随机双盲对照试验设计 ,对照药为盐酸可乐定 ,其中参附脱毒胶囊组80例 ,可乐定组30例。结果··:参附脱毒胶囊控制戒断症状的作用与可乐定相同 (P>0.05) ,控制典型戒断症状 (如骨肌肉痛 )优于可乐定 (P<0.05)。结论··:参附脱毒胶囊用于阿片类依赖的脱毒治疗疗效肯定 ,安全可靠 ,无严重不良反应。
|
关 键 词: | 参附脱毒胶囊 可乐定 海洛因依赖 戒断症状 不良反应 |
A DOUBLE- BLIND CLINICAL TRIAL OF SHENGFUTUODU CAPSULE IN THE TREATMENT OF HEROIN WITHDRAWAL SYMPTOMS |
| |
Abstract: | Objective: To evaluate the effect and safety of Shenfutuodu capsule, a traditional Chinese medicine, on alleviating opiate withdrawal symptoms in heroin addicts. Methods: A randomized, double-blind trial was carried out in 110 heroin addicts. They had been treated for 10 days. Results: In Shenfutudu group, the alleviation of withdrawal symptoms was similar to that in Clonidine group, and the effect of relieving pain was better than clonidine. Conclusion: Shenfutudu capsule is effective in the treatment of opiate withdrawal symptoms without serious side effects. |
| |
Keywords: | |
本文献已被 CNKI 万方数据 等数据库收录! |
|